ACSL4 and breast carcinoma: As a driver of ferroptosis, ACSL4 can also be used as a reference indicator of ferroptosis sensitivity [85], and breast cancer cell lines with preferential expression of ACSL4 have demonstrated increased susceptibility to ferroptosis [53].